Edesa Biotech earnings were -$5.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest EDSA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$1.6M, down 1.7% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, EDSA reported annual earnings of -$6.2M, with -26.3% growth.
On EDSA's earnings call on Invalid Date, Edesa Biotech (NASDAQ: EDSA) reported Q1 2025 earnings per share (EPS) of -$0.30, up 48.28% year over year. Total EDSA earnings for the quarter were -$1.59 million. In the same quarter last year, Edesa Biotech's earnings per share (EPS) was -$0.58.
As of the last Edesa Biotech earnings report, Edesa Biotech is currently losing money. Edesa Biotech's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$5.84 million, a 19.42% decrease year over year.
What was EDSA's earnings growth in the past year?
As of Edesa Biotech's earnings date in Invalid Date, Edesa Biotech's earnings has grown year over year. EDSA earnings in the past year totalled -$5.84 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.